S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Closing prices for crude oil, gold and other commodities
New CBOE “special perk” helps traders target income every weekend (Ad)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023
MarketBeat Week in Review – 11/27 - 12/1
New CBOE “special perk” helps traders target income every weekend (Ad)
Mega merger in the works? Humana, Cigna explore big deal
Teen girls are being victimized by deepfake nudes. One family is pushing for more protections
New CBOE “special perk” helps traders target income every weekend (Ad)
Chicago and other northern US cities scramble to house migrants with coldest weather just ahead
How major US stock indexes fared Friday, 12/1/2023

Taro Pharmaceutical Industries (TARO) Earnings Date, Estimates & Call Transcripts

$36.90
+0.90 (+2.50%)
(As of 12/1/2023 ET)
Compare
Today's Range
$36.00
▼
$37.00
50-Day Range
$32.75
▼
$38.00
52-Week Range
$22.89
▼
$42.22
Volume
29,312 shs
Average Volume
23,210 shs
Market Capitalization
N/A
P/E Ratio
42.41
Dividend Yield
N/A
Price Target
$35.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Jan. 23Estimated
Actual EPS
(Oct. 26)
$0.38 Beat By $0.20
Consensus EPS
(Oct. 26)
$0.18
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

TARO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TARO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Taro Pharmaceutical Industries Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20231$0.23$0.23$0.23
20231$0.23$0.23$0.23
Q1 20241$0.31$0.31$0.31
Q2 20241$0.18$0.18$0.18
Q3 20241$0.30$0.30$0.30
Q4 20241$0.31$0.31$0.31
FY 20244$1.10$1.10$1.10

TARO Earnings Date and Information

Taro Pharmaceutical Industries last announced its earnings data on October 26th, 2023. The reported $0.38 EPS for the quarter, beating the consensus estimate of $0.18 by $0.20. The company had revenue of $148.20 million for the quarter, compared to analyst estimates of $161.14 million. Taro Pharmaceutical Industries has generated $0.87 earnings per share over the last year ($0.87 diluted earnings per share) and currently has a price-to-earnings ratio of 42.4. Taro Pharmaceutical Industries has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 23rd, 2024 based off prior year's report dates.

Taro Pharmaceutical Industries Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
1/23/2024
Estimated)		------- 
10/26/2023Q2 2024$0.18$0.38+$0.20$0.53$161.14 million$148.20 million
7/26/2023Q1 2024$0.31$0.40+$0.09$0.53$149.00 million$158.89 million
5/23/2023Q4 2023$0.23$0.18($0.05)$0.18$150.69 million$146.59 million
1/24/2023Q3 2023$0.87$0.19($0.68)$0.19$163.12 million$139.20 million
10/27/2022Q2 2023$0.84($0.07)($0.91)($0.07)$161.02 million$130.50 million
7/27/2022Q1 2023$0.85$0.37($0.48)$0.37$149.90 million$156.67 million
5/26/2022Q4 2022$0.88$0.73($0.15)$0.73$147.00 million$143.26 million
1/27/2022Q3 2022-$0.70+$0.70$0.70-$138.98 million    
10/28/2021Q3 2021$1.02$0.66($0.36)$0.70$153.23 million$131.99 million
7/27/2021Q2 2021$0.84$1.09+$0.25$2.68$137.20 million$147.11 million
5/18/2021Q4$0.92($0.78)($1.70)$2.40$147.33 million$148.35 million
1/27/2021Q4 2020$1.01$0.86($0.15)$0.86$152.63 million$140.15 million












Taro Pharmaceutical Industries Earnings - Frequently Asked Questions

When is Taro Pharmaceutical Industries's earnings date?

Taro Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, January 23rd, 2024 based off last year's report dates. Learn more on TARO's earnings history.

Did Taro Pharmaceutical Industries beat their earnings estimates last quarter?

In the previous quarter, Taro Pharmaceutical Industries (NYSE:TARO) reported $0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $0.18 by $0.20. Learn more on analysts' earnings estimate vs. TARO's actual earnings.

How much revenue does Taro Pharmaceutical Industries generate each year?

Taro Pharmaceutical Industries (NYSE:TARO) has a recorded annual revenue of $572.95 million.

How much profit does Taro Pharmaceutical Industries generate each year?

Taro Pharmaceutical Industries (NYSE:TARO) has a recorded net income of $25.44 million. TARO has generated $0.87 earnings per share over the last four quarters.

What is Taro Pharmaceutical Industries's price-to-earnings ratio?

Taro Pharmaceutical Industries (NYSE:TARO) has a trailing price-to-earnings ratio of 42.41 and a forward price-to-earnings ratio of 26.74.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:TARO) was last updated on 12/2/2023 by MarketBeat.com Staff

My Account -